ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,219Medicare Part D Prescriptions Filled, Including Refills

Rank: 243 out of 2588

$524K Total Retail Price of All Prescriptions

Rank: 422 out of 2588

476 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 476 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

11% of this provider’s 476 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 11,170 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
FUROSEMIDE 517 505 1 5
OMEPRAZOLE 428 371 2 6
AMLODIPINE BESYLATE 427 400 3 4
SIMVASTATIN 415 386 4 1
ATENOLOL 392 369 5 14
INDAPAMIDE 375 362 6 189
LEVOTHYROXINE SODIUM 360 342 7 2
METOPROLOL TARTRATE 345 341 8 9
LISINOPRIL 332 312 9 3
PRAVASTATIN SODIUM 288 269 10 16
METFORMIN HCL 275 229 11 8
LOSARTAN POTASSIUM 257 239 12 17
WARFARIN SODIUM 247 238 13 10
TRAMADOL HCL 244 208 14 19
ATORVASTATIN CALCIUM 207 192 15 11
CITALOPRAM HBR 192 185 16 27
HYDROCHLOROTHIAZIDE 186 162 17 13
METOPROLOL SUCCINATE 185 171 18 12
ALLOPURINOL 184 167 19 33
HYDROCODONE-ACETAMINOPHEN 166 126 S3 20 7
POTASSIUM CHLORIDE 158 149 21 15
GLYBURIDE 156 143 R 22 65
ENALAPRIL MALEATE 132 120 23 31
ALENDRONATE SODIUM 109 109 24 21
SPIRONOLACTONE 106 103 25 58
RANITIDINE HCL 105 104 26 37
TRIAMTERENE-HCTZ 103 103 27 46
KLOR-CON 10 98 85 28 75
GLIMEPIRIDE 97 81 29 39
LOVASTATIN 95 90 30 34
CARVEDILOL 94 91 31 20
PANTOPRAZOLE SODIUM 93 93 32 28
DONEPEZIL HCL 92 92 33 22
DOXAZOSIN MESYLATE 92 92 33 96
NIFEDIPINE ER 91 90 35 59
FLUTICASONE PROPIONATE 87 53 36 40
CLOPIDOGREL 83 81 37 30
DIGOXIN 80 70 38 38
LANTUS 79 56 39 47
CRESTOR 78 72 40 25
ISOSORBIDE MONONITRATE ER 74 74 41 49
PLAVIX 70 65 42 43
ACTOS 69 67 43 105
AMITRIPTYLINE HCL 69 59 R 43 91
PROPRANOLOL HCL 67 67 45 128
NIFEDICAL XL 65 62 46 179
DILANTIN 64 53 47 257
ZOLPIDEM TARTRATE 64 52 47 24
INSULIN SYRINGE 61 49 49 81
SERTRALINE HCL 61 41 49 26
PAROXETINE HCL 60 53 51 71
QUINAPRIL HCL 59 57 52 148
FLUOXETINE HCL 58 52 53 92
DIOVAN 58 58 53 29
MIRTAZAPINE 57 57 55 63
PREDNISONE 56 49 56 42
NAMENDA 55 55 57 32
NEXIUM 54 29 58 41
QUETIAPINE FUMARATE 50 50 59 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.